AB Science S.A. AB Science S.A.

AB Science S.A.

AB

Rank in Stocks #22933
AB Science S.A. is a pharmaceutical company dedicated to the discovery,... AB Science S.A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors for applications in both human and animal health. Its primary drug candidate, masitinib, a tyrosine kinase inhibitor, is currently undergoing late-stage (Phase III) clinical investigations for a range of serious conditions including prostate cancer, pancreatic cancer, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Alzheimer's disease, severe asthma, and mastocytosis. Additionally, masitinib is being evaluated in Phase II clinical trials for the treatment of Covid-19. The company's pipeline also features AB8939, a synthetic microtubule destabilizer aimed at treating acute myeloid leukemia, and AB20001, which is in Phase 2 trials to assess the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients experiencing moderate to severe COVID-19. Masitinib is sold under the brand name Masivet in the European market. AB Science S.A. was founded in 2001 and is based in Paris, France.
Share Price
$0.69235838
Last synced: 2026-11-11
Market Cap
$46.96M
Change (1 day)
15.53%
Change (1 year)
-48.67%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for AB Science S.A. (AB)
Operating Margin as of November 2026 TTM: -826.53%
According to AB Science S.A.'s latest financial reports, its current operating margin (TTM) is -826.53%. At the end of 2025 the company had an operating margin of -103.66%.
Operating Margin history for AB Science S.A. from 2009 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -826.53% 697.35%
2025 -103.66% -81.73%
2024 -567.44% -59.01%
2023 -1,384.43% -16.78%
2022 -1,663.67% 93.62%
2021 -859.24% -7.78%
2020 -931.71% -16.23%
2019 -1,112.29% -34.63%
2018 -1,701.59% 4.18%
2017 -1,633.35% -18.46%
2016 -2,003.12% 76.21%
2015 -1,136.78% 56.95%
2014 -724.30% 1.66%
2013 -712.47% -10.04%
2012 -792.01% -10.01%
2011 -880.07% -15.84%
2010 -1,045.69% -60.17%
2009 -2,625.63% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.69% -100.02%
DE
19.68% -100.02%
DE
13.26% -100.02%
JP
17.08% -100.02%
CH
10.53% -100.01%
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about AB Science S.A.'s operating margin

What is AB Science S.A.'s operating margin?

AB Science S.A.'s operating margin is -826.53%, as of Nov 2026.

What was AB Science S.A.'s operating margin in 2025?

In 2025, AB Science S.A.'s operating margin was -103.66%, compared with -567.44% in 2024.

How has AB Science S.A.'s operating margin changed since 2020?

From 2020 to 2025, AB Science S.A.'s operating margin was highest in 2025 (-103.66%) and lowest in 2022 (-1,663.67%).

How does AB Science S.A.'s operating margin compare with similar companies?

AB Science S.A.'s operating margin (-826.53%) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.